Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.
Jillian S Y LauDeborah CromerMykola PinkevychSharon R LewinThomas A RasmussenJames H McMahonMiles P DavenportPublished in: The Journal of infectious diseases (2022)
Current TVR HIV cure studies are underpowered to detect statistically significant changes in frequency of viral reactivation. Alternate study designs can improve the statistical power of ATI trials.